Embryo Editing Gets Green Light in U.K.

Researchers at the Francis Crick Institute in London will use CRISPR/Cas9 to modify genes in early human embryos.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, NINASESResearchers in the U.K. will soon use precision genome-editing on human embryos in an effort to probe the mysteries of early development. And they’ll do it with the blessing of government regulators. On Monday (February 1), the U.K.’s Human Fertilisation and Embryology Authority (HFEA) made the unprecedented step of approving a project involving the editing of genes in early human embryos.

Scientists in China made headlines last year when they announced their application of CRISPR/Cas9 to modify structurally deficient human zygotes. The April Protein & Cell paper reporting the findings set off alarm bells across the life science community, dividing researchers between those who thought the move was premature and ill-advised and those who warned of the dangers of stifling such research.

The UK researchers who will apply the technique to early human embryos, which will be destroyed after seven days of growth, are the first scientists to conduct such experiments with clearance from their government’s regulatory authorities. “China has guidelines, but it is often unclear exactly what they are until you've done it and stepped over an unclear boundary,” Robin Lovell-Badge, scientific adviser to the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo